Hamed Shirzad

Title: Hamed Shirzad: Innovator in Virtual Cell Generation

Introduction

Hamed Shirzad is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of digital cell generation through his innovative patent. His work focuses on utilizing advanced neural network techniques to create virtual perturbed cells, which have potential applications in various scientific and medical fields.

Latest Patents

Hamed Shirzad holds a patent titled "Generating virtual perturbed cells utilizing a latent transfer perturbation neural network." This patent describes systems, non-transitory computer-readable media, and methods for generating a digital perturbed cell with a plurality of virtual perturbed cell response features. The invention emphasizes a flexible, modular latent transfer perturbation neural network that accurately generates virtual perturbed cells. The systems utilize a base state neural network to create a control cell latent representation based on a control cell. Additionally, a perturbation neural network generates a perturbation latent representation based on a multi-perturbation data object. The combination of these representations allows for the generation of virtual perturbed cell response features through a neural network decoder.

Career Highlights

Hamed Shirzad is currently employed at Recursion Pharmaceuticals, Inc., where he applies his expertise in neural networks and digital cell generation. His innovative approach has positioned him as a key player in the development of advanced technologies in the pharmaceutical industry.

Collaborations

Hamed has collaborated with notable colleagues, including Alisandra Kaye Denton and Berton Allen Earnshaw. These collaborations have further enhanced the research and development efforts within his field.

Conclusion

Hamed Shirzad's contributions to the field of virtual cell generation through his innovative patent demonstrate his commitment to advancing technology in the life sciences. His work at Recursion Pharmaceuticals, Inc. and collaborations with esteemed colleagues highlight his role as a leading inventor in this exciting area of research.